Iterum Therapeutics PLC (ITRM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.24
• Market Cap: $12.63M
• EPS: $-0.72
• 52-Week High: $1.50
• 52-Week Low: $0.20

Market Sentiment

Iterum Therapeutics PLC currently has a Bearish sentiment score of -0.52.

About Iterum Therapeutics PLC

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company dedicated to the development of innovative anti-infective therapies specifically targeting multidrug-resistant infections. Based in Dublin, Ireland, Iterum focuses on addressing significant unmet medical needs in the U.S. and European markets. By prioritizing solutions that combat antibiotic resistance, the company is establishing itself as a pivotal participant in the antimicrobial treatment sector, with a mission to enhance ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Iterum Therapeutics PLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ITRM pay dividends?

Iterum Therapeutics PLC (ITRM) does not currently pay a regular dividend.

What is ITRM's market cap?

Iterum Therapeutics PLC (ITRM) has a market capitalization of $12.63M with a current stock price of $0.24.